Bone Biologics Corporatio... (BBLGW)
20.20
4.60 (29.49%)
At close: Feb 26, 2025, 2:30 PM
29.49% (1D)
| Bid | n/a |
| Market Cap | 2.29M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -7.32M |
| EPS (ttm) | -0.144 |
| PE Ratio (ttm) | -140.27777777777777 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 1 |
| Avg. Volume (20D) | 725 |
| Open | 21.64 |
| Previous Close | 15.60 |
| Day's Range | 20.20 - 21.64 |
| 52-Week Range | 3.00 - 95.04 |
| Beta | 1.11 |
About BBLGW
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. Its NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. The company is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4...
Industry Medical - Devices
Sector Healthcare
IPO Date Oct 13, 2021
Employees 2
Stock Exchange NASDAQ
Ticker Symbol BBLGW
Website http://www.bonebiologics.com